BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $70,492,000 | -18.1% | 8,659,983 | -18.8% | 3.04% | -39.3% |
| Q4 2018 | $86,029,000 | +22.1% | 10,660,349 | +15.4% | 5.01% | +32.9% |
| Q3 2018 | $70,461,000 | +76.1% | 9,234,692 | +32.2% | 3.77% | +45.0% |
| Q2 2018 | $40,022,000 | +20.1% | 6,984,692 | 0.0% | 2.60% | +1.8% |
| Q1 2018 | $33,317,000 | -2.9% | 6,984,692 | 0.0% | 2.55% | -11.0% |
| Q4 2017 | $34,295,000 | -6.3% | 6,984,692 | 0.0% | 2.87% | -13.2% |
| Q3 2017 | $36,600,000 | +27.5% | 6,984,692 | +35.3% | 3.31% | +0.4% |
| Q2 2017 | $28,702,000 | -2.1% | 5,162,242 | +47.9% | 3.29% | -8.4% |
| Q1 2017 | $29,314,000 | +54.9% | 3,489,795 | +16.7% | 3.60% | +34.1% |
| Q4 2016 | $18,925,000 | +43.5% | 2,989,795 | 0.0% | 2.68% | +97.1% |
| Q3 2016 | $13,185,000 | +55.3% | 2,989,795 | 0.0% | 1.36% | +15.6% |
| Q2 2016 | $8,491,000 | +0.4% | 2,989,795 | 0.0% | 1.18% | +8.8% |
| Q1 2016 | $8,461,000 | -73.5% | 2,989,795 | -3.4% | 1.08% | -65.8% |
| Q4 2015 | $31,931,000 | +134.1% | 3,094,064 | +158.6% | 3.16% | +61.3% |
| Q3 2015 | $13,641,000 | -64.9% | 1,196,603 | -54.1% | 1.96% | -49.9% |
| Q2 2015 | $38,898,000 | -37.8% | 2,605,361 | -62.4% | 3.91% | -37.0% |
| Q1 2015 | $62,547,000 | -27.0% | 6,926,617 | -1.8% | 6.21% | -32.6% |
| Q4 2014 | $85,732,000 | +24.0% | 7,050,356 | -0.3% | 9.21% | +12.8% |
| Q3 2014 | $69,136,000 | +69.5% | 7,069,159 | +121.0% | 8.17% | +98.2% |
| Q2 2014 | $40,781,000 | -11.3% | 3,198,529 | -26.4% | 4.12% | +24.9% |
| Q1 2014 | $45,996,000 | +39.2% | 4,347,456 | 0.0% | 3.30% | -14.3% |
| Q4 2013 | $33,041,000 | -22.3% | 4,347,456 | -25.6% | 3.85% | -13.3% |
| Q3 2013 | $42,549,000 | – | 5,844,700 | – | 4.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 3,926,700 | $56,427,000 | 4.43% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $27,601,000 | 3.44% |
| HealthCor Management, L.P. | 3,849,470 | $55,317,000 | 2.39% |
| MPM BioImpact LLC | 704,767 | $10,128,000 | 1.57% |
| Baker Brothers Advisors | 12,710,818 | $182,654,000 | 0.80% |
| Bain Capital Public Equity Management II, LLC | 1,472,471 | $21,159,000 | 0.74% |
| Biondo Investment Advisors, LLC | 267,480 | $3,844,000 | 0.66% |
| North Star Investment Management Corp. | 442,900 | $6,364,000 | 0.52% |
| DOLIVER ADVISORS, LP | 100,000 | $1,437,000 | 0.48% |
| Lisanti Capital Growth, LLC | 219,450 | $3,153,000 | 0.46% |